Immunologic factors critically orchestrate endometrial receptivity for successful embryo implantation, challenging traditional hormonal views

Despite advancements in assisted reproductive technologies (ARTs), implantation failure remains a significant hurdle. Historically, research focused on hormonal and structural aspects of implantation, but it's increasingly clear that a finely tuned immune regulation is indispensable for establishing endometrial receptivity. The mid-luteal phase involves progesterone-driven decidualization and expression of adhesion molecules like integrins, defining the 'window of implantation.' This period requires immune tolerance of the semi-allogeneic embryo while maintaining pathogen protection.

This comprehensive review systematically examined the immunologic mechanisms underlying endometrial receptivity, integrating cellular, molecular, and signaling perspectives. Researchers conducted a thorough literature search across PubMed, Scopus, and Web of Science databases. The review specifically focused on synthesizing existing knowledge regarding immune cell populations, cytokine networks, intracellular pathways, and the bidirectional communication between the embryo and endometrium. It also discussed the clinical implications of these processes for implantation failure and emerging therapeutic strategies.

The review highlights that successful embryo implantation is not solely a hormonal event but critically depends on a finely regulated immune environment within the endometrium. It synthesizes evidence demonstrating that diverse immune cell populations (e.g., natural killer cells), intricate cytokine networks (e.g., IL-6, TNF-α), and specific intracellular pathways are central to establishing and maintaining endometrial receptivity. The paper emphasizes the crucial bidirectional communication between the developing embryo and the maternal endometrium, where immune signals mediate tolerance and attachment. This complex interplay ensures the endometrium is prepared to accept the semi-allogeneic embryo, preventing rejection while protecting against potential pathogens. > The review underscores that dysregulation in these immunologic mechanisms is a major contributor to recurrent implantation failure and recurrent pregnancy loss, pointing towards immune-modulating strategies as potential therapeutic avenues.